In this white paper, we draw lessons from industries as diverse as food products and toy manufacturing to illustrate how pharmaceutical companies can effectively access innovation outside the traditional in-house R&D model. To read more, click the PDF link below. A version of this article was also published in IN VIVO here.
Webinar Insights | The Rise of Competitive Rare Diseases: European Payer Perspectives
CRA recently hosted a webinar with leading European payer experts to discuss the increasingly competitive rare disease (RD) landscape